Cite
MLA Citation
Yoshiki Arakawa et al.. “MBRS-40. HMGA2 IS A PROGNOSTIC FACTOR TO INDUCE MALIGNANT PHENOTYPE IN MEDULLOBLASTOMA.” Neuro-oncology, vol. 20, no. 2, n.d., p. i137. http://access.bl.uk/ark:/81055/vdc_100095321736.0x000014
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yoshiki Arakawa et al.. “MBRS-40. HMGA2 IS A PROGNOSTIC FACTOR TO INDUCE MALIGNANT PHENOTYPE IN MEDULLOBLASTOMA.” Neuro-oncology, vol. 20, no. 2, n.d., p. i137. http://access.bl.uk/ark:/81055/vdc_100095321736.0x000014